In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Akzo Nobel scraps plan to divest Organon through IPO
15 Mar 2007
Dutch chemical giant Akzo Nobel plans to spin off 20-30% of its Organon NV pharmaceutical subsidiary in an IPO on Amsterdam's Euronext exchange. Some analysts estimate the offering will value Organon between €8-9bn ($10.2-11.5bn).
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?